Cytolytic T lymphocytes (CTL) are major effectors of clinical allograft rejection in patients treated with calcineurin inhibitor-based immunosuppression and graft endothelial cells (EC) are major targets of CTL-mediated injury. Moreover, some CTL recovered from rejecting allografts are specific for EC and not other graft, cell types suggesting that such CTL arise in response to stimulation by graft EC. The investigators believe that improvements in post-transplant therapy should target those mechanisms least well controlled by current therapy, ie., CTL-mediated EC injury by either EC-selective or conventional MHC-restricted CTL, and that such improvements will depend on better understanding these mechanisms. This proposal (1) will investigate mechanisms utilized by EC to influence CTL maturation as well as the effects of modifying human EC, e.g., by cytokine treatments or gene transduction, on this process;will examine the role of adhesion molecules in the molecular basis of EC-selectivity;will compare the effects of adoptive transfer of EC-selective vs. conventional CTL in our huPBL-SCID/bg mouse models of allograft rejection;and will compare the phenotypes of EC-selective vs. conventional CTL using microarrays to develop biomarkers in order to identify EC-selective CTL in rejecting tissues generated both in huPBL-SCID/bg mouse models of allograft injury and in clinical biopsy specimens;(2) will determine the death pathways activated within human EC in response to EC-selective and to conventional CTL in culture and in biopsy specimens and identify strategies to block these responses;and (3) will investigate the mechanisms by which treatment with IL-11 or erythropoietin protect EC from CTL, paying particular attention to the role of STATS signaling. We will use microarrays to identify novel protective molecules. These data will provide a rational basis for developing new, complementary strategies to further reduce the incidence and consequences of allograft rejection.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL062188-10
Application #
7642483
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Schwartz, Lisa
Project Start
2000-01-10
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$433,669
Indirect Cost
Name
Yale University
Department
Pathology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Harding, Martha J; Lepus, Christin M; Gibson, Thomas F et al. (2010) An implantable vascularized protein gel construct that supports human fetal hepatoblast survival and infection by hepatitis C virus in mice. PLoS One 5:e9987
Kirkiles-Smith, Nancy C; Harding, Martha J; Shepherd, Benjamin R et al. (2009) Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation 87:189-97
Al-Lamki, R S; Brookes, A P; Wang, J et al. (2009) TNF receptors differentially signal and are differentially expressed and regulated in the human heart. Am J Transplant 9:2679-96
Gerber, Scott A; Yatsula, Bogdan; Maier, Cheryl L et al. (2009) Interferon-gamma induces prolyl hydroxylase (PHD)3 through a STAT1-dependent mechanism in human endothelial cells. Arterioscler Thromb Vasc Biol 29:1363-9
Ullrich, Sebastian; Schinke, Susanne; Both, Markus et al. (2009) Refractory central nervous system vasculitis and gastrocnemius myalgia syndrome in Crohn's disease successfully treated with anti-tumor necrosis factor-alpha antibody. Semin Arthritis Rheum 38:337-47
Li, Jie H; D'Alessio, Alessio; Pober, Jordan S (2009) Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells. Am J Pathol 175:1124-35
Al-Lamki, Rafia S; Bradley, John R; Pober, Jordan S (2008) Endothelial cells in allograft rejection. Transplantation 86:1340-8
Gerber, Scott A; Pober, Jordan S (2008) IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells. J Immunol 181:1052-62
Gleissner, Christian A; Zastrow, Arne; Klingenberg, Roland et al. (2007) IL-10 inhibits endothelium-dependent T cell costimulation by up-regulation of ILT3/4 in human vascular endothelial cells. Eur J Immunol 37:177-92
Yamakuchi, Munekazu; Kirkiles-Smith, Nancy C; Ferlito, Marcella et al. (2007) Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci U S A 104:1301-6

Showing the most recent 10 out of 20 publications